Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test
Merck today announced a non-exclusive license agreement with Laboratory Corporation of America Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.
Read more...
News briefing: 2329 July 2010
The week in science.
Read more...
Idenix Pharmaceuticals Reports Second Quarter 2010 Financial Results and Provides Research and Development Update on ...
CAMBRIDGE, Mass. , July 26 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX - News ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the second quarter and six months ended June 30, 2010 . At June 30, 2010 , Idenix's cash and cash equivalents totaled $51.0 ...
Read more...
Does Circumcision Prevent HIV?
Offering circumcision would have a very small effect on reducing HIV transmission rates among gay and bisexual men in the United States, according to researchers presenting findings at the XVIII International AIDS Conference held this week in Vienna, Austria.
Read more...
Digest: Dez Bryant comes to terms with the Cowboys
Dez Bryant agreed to terms of a contract with the Dallas Cowboys on Thursday, making the receiver the first of this years NFL first-round picks with a deal.
Read more...
|